Cargando…
A review of the fixed dose use of new oral anticoagulants in obese patients: Is it really enough?
Obesity is a significant cause of morbidity and mortality, and it is becoming increasingly prevalent worldwide. Altered pharmacodynamics and pharmacokinetics of drugs in obese patients require dose adjustment according to body weight. New oral anticoagulants (NOACs), which are more frequently used f...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Kare Publishing
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5368456/ https://www.ncbi.nlm.nih.gov/pubmed/26663225 http://dx.doi.org/10.5152/AnatolJCardiol.2015.6532 |